Human lung adenocarcinoma, the most prevalent form of lung cancer, is characterized by many molecular abnormalities. K-ras mutations are associated with the initiation of lung adenocarcinomas, but K-ras-independent mechanisms may also initiate lung tumors. Here, we find that the runt-related transcription factor Runx3 is essential for normal murine lung development and is a tumor suppressor that prevents lung adenocarcinoma. Runx3À/À mice, which die soon after birth, exhibit alveolar hyperplasia. Importantly, Runx3À/À bronchioli exhibit impaired differentiation, as evidenced by the accumulation of epithelial cells containing specific markers for both alveolar (that is SP-B) and bronchiolar (that is CC10) lineages. Runx3À/À epithelial cells also express Bmi1, which supports self-renewal of stem cells. Lung adenomas spontaneously develop in aging Runx3 þ /À mice (B18 months after birth) and invariably exhibit reduced levels of Runx3. As K-ras mutations are very rare in these adenomas, Runx3 þ /À mice provide an animal model for lung tumorigenesis that recapitulates the preneoplastic stage of human lung adenocarcinoma development, which is independent of K-Ras mutation. We conclude that Runx3 is essential for lung epithelial cell differentiation, and that downregulation of Runx3 is causally linked to the preneoplastic stage of lung adenocarcinoma.
Introduction
Lung cancer is the leading cause of cancer mortality worldwide, with more than 1 million associated deaths per year (Peacock and Watkins, 2008) . The majority of lung tumors can be divided into four major histological types including small cell lung cancer and three types of non-small cell lung cancer: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma (Petersen and Petersen, 2001; Collins et al., 2007) . Among these four types, adenocarcinoma is the most common form of lung cancer, and its frequency is increasing rapidly (Minna et al., 2002) . The current paradigm of lung adenocarcinoma is that the tumor develops either by stepwise progression with sequential morphologic changes, from atypical adenomatous hyperplasia (AAH) to bronchioloalveolar carcinoma (BAC) and then to invasive adenocarcinoma, or through a nonstepwise pathway of de novo invasive adenocarcinoma (Wistuba and Gazdar, 2006) .
The mutational activation of oncogenes, including Myc, K-Ras, EGFR, and Her2/neu, and the inactivation of tumor suppressor genes such as p53, Rb, and p16 (Minna et al., 2002) have recently been documented in lung adenocarcinomas. In addition to genetic alteration, many known and putative tumor suppressor genes are inactivated by promoter hypermethylation (Belinsky et al., 1998; Zochbauer-Muller and Minna, 2000; Li et al., 2004) . Among these genetic and epigenetic events, mutations of K-Ras codon 12 have been postulated as an initial event in the development of lung adenocarcinomas by the stepwise progression pathway (Jackson et al., 2001; Tuveson et al., 2004; Kim et al., 2005a; Wistuba and Gazdar, 2006) .
During mouse embryogenesis, the lung epithelium develops in two distinct phases. During days 13-15 of early embryo development (E13-E15, early phase), the expression of cell surface markers is identical in all epithelial cells. The late phase (E16-E18) is characterized by the emergence of differentiated cell types for alveoli and bronchioli (Wuenschell et al., 1996) . The alveolar epithelium includes alveolar epithelial type 1 (AT1) and AT2 cells, which are derived from common alveolar stem cells (AT2 cells) (Bishop, 2004; Reddy et al., 2004) . The bronchiolar epithelium includes basal cells, ciliated cells, Clara cells, goblet cells, and a few pulmonary neuroendocrine cells (Bishop, 2004) . There are at least three types of progenitor cells that have important functions in maintaining the bronchiolar epithelium of the lung: (1) basal cells, which generate Clara cells and ciliated cells; (2) variant Clara cells (bronchiolar stem cells), which also generate Clara cells, goblet cells, and bronchiolar neuroendocrine cells; and (3) bronchioalveolar stem cells (BASCs), which generate Clara cells and AT2 cells. It has been reported that the BASCs express markers of both alveolar stem cells and bronchiolar stem cells (SP-C and CC10, respectively) and are the origins of lung adenocarcinomas (Kim et al., 2005a) .
The RUNX family of transcription factors has a pivotal function in normal development and the development of neoplasias (Lund and van Lohuizen, 2002) . RUNX1 and RUNX2 are essential for hematopoiesis and osteogenesis, respectively, and are often mutated in leukemia and bone disease (Okuda et al., 1996; Lee et al., 1997; Look, 1997; Mundlos and Olsen, 1997; Otto et al., 1997) . RUNX3 is involved in neurogenesis Levanon et al., 2002) and thymopoiesis (Taniuchi et al., 2002; Woolf et al., 2003) , and it functions as a tumor suppressor in gastric cancer (Guo et al., 2002; Li et al., 2002; Kim et al., 2005b; Ito et al., 2008) . RUNX3 regulates target gene expression by forming a complex with Smads, the transducer of TGF-b signaling. RUNX3 is required for the TGF-b-mediated induction of p21 WAF1/Cip1 , a negative regulator of the cell cycle, and Bim, a proapoptotic gene (Chi et al., 2005; Yano et al., 2006) . Recently, it was shown that RUNX3 forms a ternary complex with b-catenin/TCF4 and attenuates Wnt signaling activity, thereby suppressing the development of colon cancer (Ito et al., 2008) . RUNX3 was also identified as one of the five most informative genes of the CpG island methylator phenotype of colorectal cancer (Weisenberger et al., 2006) . In addition to gastric and colon cancer, RUNX3 is frequently inactivated in cancers of the lung, bladder, pancreas, liver, prostate, bile duct, breast, larynx, esophagus, and testicular yolk sac by either DNA hypermethylation or mislocalization of the protein in the cytoplasm (Kato et al., 2003; Goel et al., 2004; Kang et al., 2004; Li et al., 2004; Tozawa et al., 2004; Xiao and Liu, 2004; Ito et al., 2005; Kim et al., 2005b; Lau et al., 2006) . Among the lung cancers, RUNX3 promoter hypermethylation is preferentially found in lung adenocarcinomas (Sato et al., 2006) . The frequent silencing of RUNX3 by promoter hypermethylation in the preneoplastic stage of lung adenocarcinoma (30-70% of atypical AAHs and BACs) (Licchesi et al., 2008) has suggested that RUNX3 inactivation could be an early event during the development of lung adenocarcinoma. However, it is not clear whether the inactivation of RUNX3 is a cause of lung adenocarcinoma development.
Although many transcription factors that have essential functions in lung development have been identified, there is no earlier evidence that any of these proteins are associated with lung tumorigenesis (Costa et al., 2001; Cardoso and Lu, 2006) . Our results provide the first evidence that Runx3 is an essential transcription factor for the late phase of murine lung development, and that Runx3 downregulation is an early event in the development of lung adenocarcinoma by the stepwise progression pathway.
Results

Disruption of Runx3 results in lung epithelial hyperplasia
As most Runx3À/À mice died within 24 h of birth because of breathing abnormalities, we examined the lungs of Runx3À/À FVB mice, which is known to be susceptible for tumorigenesis. Histochemical staining revealed that Runx3À/À mice had developed lung hyperplasia by the first day of birth (P1) (Figure 1a ). The lung hyperplasia began to develop in mouse embryos at E17.5 ( Figure 1a ). Immunohistochemical staining revealed low levels of Runx3 in wild-type (WT) mouse lungs at E15.5, and Runx3 became progressively more abundant in bronchiolar and alveolar cells at E17.5 and into adulthood (Figure 1b) . Runx3 was detected in the nuclei of WT lung cells, but not in those of Runx3À/À mice (Supplementary Figure 1) .
Immunostaining revealed that cells containing the proliferation marker Ki67 were more abundant in the Runx3À/À lungs (84%) than in WT lungs (53%) at E17.5 (Figure 1c ). Ki67 levels were maintained in most of the bronchiolar epithelial cells of Runx3À/À mice until P1, whereas Ki67-positive cells were rare in WT mice at the same stage ( Figure 1c ). These results suggest that the lung hyperplasia in Runx3À/À mice is due to increased proliferation, and that Runx3 has a function in the inhibition of lung epithelial cell proliferation during the late phase of lung development (from E17.5 to P1).
It has been reported that Runx3 is essential for the transcriptional upregulation of the proapoptotic gene Bim in mouse gastric epithelial cells (Yano et al., 2006) . Therefore, we examined the level of Bim in Runx3 þ / þ and Runx3À/À lungs. Immunostaining revealed that the level of Bim was markedly reduced in Runx3À/À lung epithelial cells. This result suggests that the Runx3 regulates apoptosis by inducing Bim expression in lung epithelium as well as in gastric epithelium (Supplementary Figure 2 ).
AT2 cells are more numerous in Runx3À/À lung alveoli AT2 cells have round nuclei and prominent lamellar bodies and are readily distinguished from AT1 cells by transmission electron microscopy (TEM). On the basis of TEM analyses, the alveolar septa of WT mice contained many AT1 cells and a few AT2 cells. In comparison, Runx3À/À mice contained a large population of AT2 cells and only a small number of AT1 cells (a) Analysis of lung tissues from WT (Runx3 þ / þ ) and Runx3À/À mice by hematoxylin and eosin staining. At P1 (the first day of birth), the lungs of Runx3À/À mice had narrow alveolar spaces, whereas WT lungs had large expanded alveoli (top panels). At E15.5 (embryonic day 15.5), there were no apparent differences between the animals (second panels). At E17.5 and P1, the lungs of Runx3À/À mice exhibited abnormal development and more cells than WT lungs (third and fourth panels). (b) Analysis of Runx3 expression in WT lungs by immunohistochemical staining. Runx3 was detected as early as E15.5, and the protein levels increased with development, becoming more prominent at E17.5 and into adulthood, in both alveolar and bronchiolar cells, B, bronchiolus. (c) Analysis of the interphase marker Ki67 in Runx3À/À and WT lungs by immunostaining. At E17.5, Ki67-positive cells were present in alveoli as well as bronchioli. There were more Ki67-positive cells in the lungs of Runx3À/À mice than in the lungs of WT mice. At P1, there were a number of Ki67-positive cells in Runx3À/À bronchioli, but few in WT bronchioli. B, bronchiolus. (d) Transmission electron micrographs of WT and Runx3À/À lung tissues. The frequency of AT2 cells (indicated by green arrows) was higher in Runx3À/À lungs than in WT lungs. Red and yellow arrowheads indicate AT1 cells and lamella bodies, respectively.
( Figure 1d ). These results suggest that Runx3 is required for the terminal differentiation of AT2 cells to AT1 cells.
Runx3 is essential for bronchiolar epithelial cell differentiation
We examined lung tissues for the presence of alveolar lineage-specific markers (SP-B and SP-C) and a bronchiolar lineage-specific marker (CC10, also called CCA, CCSP, or Scgb1a1) by immunohistochemical staining. Bronchiolar epithelial cells in WT lungs were positive for CC10, but negative for SP-B (Figure 2a ). However, most of the bronchiolar epithelial cells in Runx3À/À lungs contained SP-B as well as CC10 (Figure 2a ). In both WT and Runx3À/À lungs, SP-C was not detected in bronchioli, but was present in the alveoli (Figure 2a) . We confirmed the presence of SP-B/CC10 double-positive cells in Runx3À/À bronchioli by double immunofluorescence staining ( Figure 2b ). Thus, Runx3À/À mice harbored a population of bronchiolar epithelial cells that contained both SP-B and CC10, and these were not detectable in the WT lungs.
Polycomb group member Bmi1 is essential for the self-renewal and maintenance of BASCs and is, therefore, used as a BASC marker (Valk-Lingbeek et al., 2004; Dovey et al., 2008) . Bmi1 is also known as a marker of various cancer cells (Bea et al., 2001; Vonlanthen et al., 2001; Dimri et al., 2002; Leung et al., 2004) . Interestingly, Bmi1 was detected in most of the bronchiolar epithelial cells of the mouse Runx3À/À lungs ( Figure 2a ). These results together show that SP-B/CC10/Bmi1 positive, but SP-C negative (SP-
TEM analyses revealed that Clara cells, which are normal constituents of WT bronchioli, and ciliated cells, which originate from Clara cells, were absent from the Runx3À/À bronchioli ( Figure 2c ). Instead, cells with a columnar morphology were arrayed in the Runx3À/À bronchioli. These are likely to represent the SP-
Thus, the normal differentiation of bronchiolar epithelial cells is impaired in Runx3À/À mice.
Runx3 þ /À mice are highly susceptible to lung adenomas The Knudson paradigm of tumor suppressor gene inactivation postulates that mice that are heterozygous for a tumor suppressor are phenotypically normal, but susceptible to tumorigenesis. We analyzed the lungs of Runx3 þ /À mice and found that up to 12 months after birth, there were no marked histological abnormalities. However, at 18 months of age, numerous glandular hyperplastic lesions were found in most of the Runx3 þ /À lungs ( Figure 3a , upper panels). In addition, 85 out of 100 Runx3 þ /À mice developed lung adenomas (B0.5 mm in diameter; an average of 2-3 adenomas per mouse) in peripheral regions of the lungs (Figure 3a , lower panels). Lung adenomas are neoplasms with papillary, solid, or mixed architecture that distort or obliterate the alveolar septae, and are considered to be the mouse counterpart of human AAHs or BACs. The spontaneous adenomas in Runx3 þ /À lungs were all of the papillary subtype ( Figure 3a , lower panels). Lung adenocarcinomas (5 mm in diameter, on average) were found in 3 out of 100 Runx3 þ /À mice (Figure 3b ). In comparison, glandular hyperplasia and lung adenoma were very rare in WT mice (1 in 20 mice). Immunostaining revealed that the cells of the spontaneous adenomas in Runx3 þ /À mice expressed only the AT2-specific markers; they were SP-B/SP-C positive and CC10 negative (Figures 3c and d summarizes the incidence of lung adenoma in WT and Runx3 þ /À mice).
Early onset of adenoma in Runx3 þ /À mice by urethane treatment We treated mice with urethane, an environmental carcinogen that induces lung adenomas, and compared adenoma development in Runx3 þ /À and WT mice. The result revealed that Runx3 þ /À mice were more sensitive to urethane than WT mice. Twelve weeks after a low dose of urethane treatment (500 mg per kg body weight), 85% (17/20) of the Runx3 þ /À mice developed adenomas, compared with only 15% (3/20) of the WT mice ( Figure 3e ). The average number of urethane-induced adenomas per animal was similar in Runx3 þ /À and WT mice (1.7 adenomas/mouse). This higher sensitivity to urethane treatment of Runx3 þ /À mice provides additional evidence that Runx3 functions as a tumor suppressor of lung adenocarcinoma.
K-ras mutation-independent lung adenoma development in Runx3 þ /À mice K-ras mutations are found in most chemically induced mouse lung adenomas (Dovey et al., 2008) and in about 40% of human AAHs (Westra et al., 1996) . To determine whether the adenomas in Runx3 þ /À mouse lungs carried K-Ras mutations, we sequenced the K-ras gene in 10 spontaneous and 10 urethane-induced lung adenomas from Runx3 þ /À mice. Unexpectedly, none of the spontaneous adenomas carried K-ras mutations, and K-ras mutations were rare in the urethane-induced adenomas (2 out of 10). However, two out of three spontaneous adenocarcinomas from Runx3 þ /À lungs carried K-ras mutations. All of the mutations were A to T transitions in codon 61 (Figure 3f ). These results suggest that K-Ras mutations are not essential for adenoma development in Runx3 þ /À mice, but that this codon 61 mutation seems to be associated with the progression to malignant carcinoma.
Runx3 is downregulated in spontaneous and urethane-induced lung adenomas As K-ras mutations were rare in the lung adenomas of Runx3 þ /À mice, we used immunostaining to examine Runx3 protein levels in glandular hyperplasias, adenomas, adenocarcinomas, and normal lung tissues of Runx3 þ /À mice. The Runx3 protein levels were significantly decreased in all spontaneous glandular hyperplasias, adenomas, and adenocarcinomas compared with normal lung tissues in the Runx3 þ /À mice ( Figures 4A, a-f, k, l) . Runx3 protein levels were also reduced in urethane-induced adenomas of both WT and Runx3 þ /À mice ( Figures 4A, g-j) . Interestingly, all the adenomas contained an even distribution of two kinds of cells, those with low levels of Runx3 (indicated by arrowheads in the figure) and those with no detectable Runx3 (arrows). It is unclear how these two kinds of cells were generated and whether this phenomenon is associated with the development of the adenomas. Additional cases are shown in Supplementary Figure 3a .
To understand whether the decrease in the Runx3 protein level is associated with the decrease in Runx3 mRNA, we measured the levels of Runx3 mRNA in the lungs of Runx3 þ / þ and Runx3À/À mice and in lung adenomas by semiquantitative RT-PCR. Runx3 expression is regulated by two promoter regions designated P1 and P2 in a cell type-specific manner (Bangsow et al., 2001) . In the mouse lung, only Runx3 mRNA (type 2 Runx3 mRNA) driven by P2 was detected (Supplementary Figure 3b) . In all the lung adenomas, the type 2 
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Runx3 mRNA level was significantly reduced and the type 1 Runx3 mRNA was not detected (Supplementary Figure 3b) . This result suggests that type 2 Runx3 is specifically expressed in mouse lung and it is downregulated in lung adenomas at the transcriptional level. Analysis of the methylation status of the CpG island in the Runx3 promoter revealed that the promoter was methylated in B60% of lung adenomas, both spontaneous and urethane induced, in Runx3 þ /À mice ( Figure 4B ). Thus, Runx3 promoter hypermethylation was associated with lung adenoma development, and this probably contributed to the downregulation of Runx3 expression. The lack of Runx3 promoter hypermethylation in 40% of the lung adenomas suggests that there could be other mechanisms in addition to DNA methylation that contributed to the reduced levels of Runx3 protein in adenoma cells.
Morphological characteristics of lung adenomas in Runx3 þ /À mice
The adenomas that spontaneously developed in Runx3 þ /À mice were further examined by TEM. Interestingly, all the adenoma cells contained Clara Figure 4 Reduced levels of Runx3 in glandular hyperplasias, adenomas, and adenocarcinomas. (A) Immunostaining of various tissues using the anti-RUNX3 antibody (R3-1E10). The tissues analyzed were normal (control) tissue (a, b), glandular hyperplasia lesions (c, d), spontaneous adenomas (e, f), and urethane-induced adenomas (g, h) from a Runx3 þ /À mouse; urethane-induced adenomas (i, j) from a WT mouse; and spontaneous adenocarcinoma (k, l) from a Runx3 þ /À mouse. Arrowheads indicate cells with low levels of Runx3; arrows indicate cells with no detectable Runx3. (B) Analysis of Runx3 promoter methylation in spontaneous and urethaneinduced lung adenomas of Runx3 þ /À mice by methylation-specific PCR. The promoter was unmethylated in normal lung tissues from WT and Runx3 þ /À (Het) mice. In three out of five spontaneous adenomas and three out of five urethane-induced adenomas from Runx3 þ /À mice, the Runx3 promoter was methylated. M, methylated DNA-specific PCR; U, unmethylated DNA-specific PCR. T1-T10 indicate adenomas obtained from different mice. (C) Electron micrographs of spontaneous adenomas from Runx3 þ /À mice. Most of the adenoma cells had Clara granules (indicated by red arrows), which are characteristic of bronchiolar epithelial cells.
Role of Runx3 in lung tumorigenesis K-S Lee et al granules (which are specific for bronchiolar stem cells) ( Figure 4C ). This is a morphological characteristic of human AAHs (Mori et al., 1998; Osanai et al., 2001) . Thus, although these adenoma cells express alveolarspecific markers (Figure 3c ), the cells also have the morphological characteristics of bronchiolar cells, suggesting that the adenomas might have originated from common ancestors of the alveolar and bronchiolar epithelial cells.
Detection of SP-B, CC10, and Bmi1 in cells near lung adenocarcinomas As we found that SP-B þ /CC10 þ /Bmi1 þ /SP-C -cells were common in Runx3-null (Runx3À/À) bronchioli (Figure 2a) , we suspected that Runx3-downregulated lung adenomas or adenocarcinomas may also contain similar cells. Immunostaining of adenocarcinomas from Runx3 þ /À lungs revealed that the SP-
þ /SP-C -cells actually accumulated in the bronchioli near the adenocarcinomas ( Figure 5 ). This, together with the reduced levels of Runx3 in lung glandular hyperplasia ( Figure 4A ), suggests that inactivation of Runx3 might be associated with the initiation of lung tumorigenesis, and that additional changes are required for the development of adenomas and adenocarcinomas.
þ /SP-C -cells were found only near the adenocarcinomas carrying K-ras mutations, suggesting that K-ras may contribute to the proliferation of the cells.
Deregulation of RUNX3 in human lung adenocarcinomas
As RUNX3 promoter hypermethylation is associated with human adenocarcinomas (Sato et al., 2006) , we analyzed RUNX3 protein levels in 14 cases of preneoplastic lesions (AAH and/or BAC) and 57 human primary lung adenocarcinomas. In normal lung cells, RUNX3 was easily detected in the nucleus, but not the cytoplasm (Figure 6a , top panels). RUNX3 levels were reduced in 93% of the AAH/BAC samples and 63% of adenocarcinomas (Figures 6a and b) . In most of the adenocarcinomas with normal levels of RUNX3 in the nucleus, we observed some RUNX3 that was mislocalized in the cytoplasm (Figure 6a , bottom panels). At this stage, it is unclear whether this cytoplasmic mislocalization of RUNX3 is also associated with adenocarcinoma development. Additional cases are shown in Supplementary Figure 4 and the details of each case are presented in Supplementary Table 1.
Discussion
Runx3 is required for the control of differentiation and proliferation of lung epithelial cells The most prominent abnormal phenotype of Runx3À/À lungs was alveolar hyperplasia because of the increased numbers of AT2 cells, which are alveolar precursor cells with the capacity to proliferate. On the other hand, the frequencies of AT1 cells, which are derived from AT2 cells, were decreased. These results suggest that the lack of Runx3 resulted in the prolonged proliferation of AT2 cells and a failure of the AT2 cells to differentiate into terminal AT1 cells, leading to alveolar hyperplasia. 
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Hyperplasia was not evident in bronchioli of Runx3À/À lungs, although the bronchiolar epithelial cells also seemed to retain proliferation capacity based on the presence of Ki67 even at the postnatal stage. Interestingly, a number of Runx3À/À bronchiolar epithelial cells contained markers for both alveolar epithelial cells (SP-B) and bronchiolar epithelial cells (CC10), but not another alveolar epithelial cell marker (SP-C). Most of the Runx3À/À bronchiolar epithelial cells also contained Bmi1, which is essential for the self-renewal of stem cells (Valk-Lingbeek et al., 2004; Dovey et al., 2008) and is known as a marker of various cancer cells (Bea et al., 2001; Vonlanthen et al., 2001; Dimri et al., 2002; Leung et al., 2004) . The accumulation of the SP-
þ /SP-C -cells suggests that differentiation of the lung epithelial progenitor cells was impaired in the Runx3À/À bronchioli. Lung epithelial progenitor cells express both alveolar-specific and bronchiolarspecific markers (Wuenschell et al., 1996) . For example, the BASCs express both SP-C and CC10. This study provides evidence for a critical function of Runx3 in murine lung epithelial progenitor cell differentiation. Further lineage tracing analyses are required to understand which types of progenitor cell differentiation are impaired by the disruption of Runx3.
Runx3 insufficiency leads to the onset of lung adenomas in mice
We showed that all the Runx3 þ /À mice spontaneously developed glandular hyperplasia, and 85% of the mice developed adenomas in the lungs by 18 months after Figure 6 Deregulation of RUNX3 in human lung adenocarcinomas. (a) Human primary lung adenocarcinomas (ADC) (57 cases) and AAH/BACs (14 cases) were analyzed by immunostaining with the anti-RUNX3 antibody. Several representative slides are shown. The level of RUNX3 protein and its localization were similar to those of normal control lung cells in 2 of the 71 samples. The other 69 cases were classified based on the type of RUNX3 deregulation: in some cases, RUNX3 was localized in the nucleus, but was present at reduced levels (second-fourth panels; 'nucleus, downregulation'). In others, the RUNX3 levels were normal, but the protein was localized in the cytoplasm as well as the nucleus (bottom panels; 'nucleus and cytoplasm'). birth. Although it was rare, 3% of the mice developed adenocarcinomas. Interestingly, Runx3 levels were reduced in all of the spontaneous cases of glandular hyperplasia, adenoma, and adenocarcinoma, compared with the levels in normal lungs of Runx3 þ /À mice. Furthermore, Runx3 þ /À mice were highly sensitive to urethane-induced lung carcinogenesis, and all of the urethane-induced adenomas also showed reduced levels of Runx3. These lines of evidence fit well with the Knudson paradigm that the heterozygotes for a tumor suppressor gene are susceptible to tumorigenesis. Therefore, our results show that Runx3 is a tumor suppressor for lung adenocarcinoma, and that Runx3 insufficiency might lead to the initiation of a stepwise process of lung adenocarcinoma development.
In addition, we found that SP-
-cells, which accumulated in the bronchiolar epithelia of RunxÀ/À lungs, also accumulated near spontaneous adenocarcinomas in Runx þ /À lungs. This result provides additional evidence that the downregulation of Runx3 could be a critical early event in lung tumorigenesis.
Runx3 insufficiency leads to lung adenomas without K-ras mutations in mice K-Ras mutations are found in 39% of human AAH/ BACs and 25-50% of human lung adenocarcinomas (Westra et al., 1996) . On the other hand, such mutations are found in 490% of chemically induced mouse lung tumors (Malkinson, 1998) . These results indicate that human adenocarcinomas develop through both K-rasdependent and -independent pathways, whereas the chemically induced mouse model represents a K-rasdependent pathway. Our results indicate that most of the Runx3 þ /À mice spontaneously develop lung adenomas without K-ras mutations. Notably, low doses of urethane stimulated the early onset of adenomas in Runx3 þ /À lungs, and Runx3 levels were reduced in all of the induced adenomas, whereas K-ras mutations were found in only 20% of the adenomas. This is far less than the incidence of K-ras mutations (75%) in urethanetreated normal mice (Cazorla et al., 1998) . As the majority of human AAHs and adenocarcinomas do not carry K-Ras mutations, but do show reduced levels of RUNX3, the Runx3 þ /À mice represent an attractive model for lung tumorigenesis in human beings. Interestingly, K-ras mutations were found in two out of three cases of the adenocarcinomas that spontaneously developed in Runx3 þ /À lungs. This may indicate that K-ras mutation is a secondary event associated with the progression of adenoma to adenocarcinoma in individuals with reduced levels of Runx3. This possibility is supported by our earlier observation that Runx3 is induced by the oncogenic ras mutation and stimulates apoptosis, suggesting that Runx3 is involved in the oncogene surveillance mechanism (Chi et al, 2009) . Therefore, downregulation of Runx3 may induce lung adenoma development by disturbing lineage-specific differentiation of lung epithelial cells and by promoting progression to adenocarcinoma by allowing oncogenic mutations. Bmi1 has been suggested to have a vital function in K-ras-dependent lung tumorigenesis, as shown by the dramatic decrease in tumor development induced by a lack of Bmi1 in an oncogenic K-ras G12D mouse model of lung cancer (Dovey et al., 2008) . Therefore, downregulation of Runx3, which results in an increase in Bmi1 expression, may cooperate with K-ras G12D in the development of lung adenocarcinoma. Fainaru et al. (2004) reported that Runx3À/À mice (ICR, MF1 background) survived until adult age, and that adult Runx3À/À mice displayed a prominent eosinophilic infiltration in their lungs without lung epithelial hyperplasia. In contrast, mice with the Runx3À/À genotype in the FVB background died soon after birth and exhibited lung epithelial hyperplasia during embryogenesis. Although the reason for this discrepancy is unclear, it might reflect differences in mouse strains, as the phenotypes of Runx3 mutant mice vary greatly depending on the strain. For example, Runx3-null balb/c mice can survive until adulthood , whereas FVB and C57BL/6 mice carrying the same Runx3 mutant allele die soon after birth (Ito et al., 2008) . Differences in the gene targeting strategies could also explain the differences (Ito et al., 2009) .
In summary, our results show that Runx3 is an essential transcription factor for the late phase of murine lung development, and that an insufficiency of Runx3 is associated with the early stage of lung tumorigenesis. This work provides an animal model of human lung adenocarcinoma development without K-Ras mutations.
Materials and methods
Runx3 knock-out mice
The generation of Runx3 þ /À C57BL/6 mice was described earlier (Li et al., 2002) . Runx3 þ /À FVB mice were generated by interbreeding with Runx3 þ /À C57BL/6 mice, followed by backcrossing with FVB mice for 410 generations. The animals were maintained in pathogen-free conditions and monitored daily. Runx3À/À FVB mice died soon after birth (within 24 h) because of breathing abnormalities, as did the Runx3À/À C57BL/6 mice. Animal studies were performed in accordance with the guidelines of the Institutional Animal Care Committee of Chungbuk National University.
Human primary tumor samples Paraffin-embedded tissue samples from patients that had undergone resections of primary lung cancer were obtained from Bundang Hospital at Seoul National University. On the basis of the availability of adequate tissue, 57 lung adenocarcinomas and 14 AAH/BACs were analyzed. Human tissue samples were analyzed with prior approval from the Institutional Ethics Committee of Bundang Hospital of Seoul National University.
Histology and immunohistochemistry
Adult mouse lungs and fetal embryos were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS), and then embedded in paraffin using standard procedures. Serial paraffin sections (5 mm thickness) were prepared and individual slides were stained with hematoxylin and eosin. Histological staining was performed by a certified pathologist. Runx3 antigen retrieval was achieved by incubation in 2 M HCl for 10 min at room temperature; for all other experiments, we used citrate buffer, pH 6.0. After antigen retrieval, immunohistochemical analyses (immunostaining) were performed using the DakoCytomation Envision þ System (using horseradish peroxidase with diaminobenzidine enhancer) (Dako, CA, USA), according to the manufacturer's instructions. Staining intensities for Runx3 were assessed by three reviewers including two pathologists. Staining of o25% compared with normal lungs was classified as low expression. The following primary antibodies were used for immunostaining and/or immunofluorescence staining: anti-SP-A, -SP-B, -SP-C, -SP-D, -CC10, and -Bim (Santa Cruz Biotechnology Inc., CA, USA); anti-RUNX3 (R3-1E10); anti-Bmi (Abcam, UK); and anti-Ki67 (Dako). Alexa Fluor-conjugated secondary antibodies (Invitrogen, Carlsbad, CA, USA) were used for immunofluorescence staining. The stained sections were examined with an Olympus U-LH100HG microscope.
Transmission electron microscopy
To evaluate the ultrastructural features of broncheoalveolar cells, lung specimens were fixed directly in half-strength Karnovsky's fixative and then processed for TEM using standard procedures, followed by staining with uranyl acetate and lead citrate. Specimens were examined using an H-7600 Hitachi transmission electron microscope.
Semiquantitative RT-PCR Total RNA was isolated with Trizol, and 2 mg total RNA was reverse transcribed using the SuperScript tm first-strand synthesis system for reverse transcription-polymerase chain reaction (RT-PCR) (Invitrogen) according to the complementary DNA synthesis protocol from Invitrogen. Transcription of RUNX3 products was evaluated using RT-PCR and electrophoresis in 2% agarose gels. RT-PCR was performed for 25 cycles using P1F primer (5 0 -atggcttccaacagcatctttgac-3 0 ) and P-comR primer (5 0 -acagtgaccttgatggctcg-3 0 ) for the amplification of Runx3 mRNA from the P1 promoter. P2F primer (5 0 -atgcgtattcccgtagaccc-3 0 ) and P-comR primer were used for the amplification of Runx3 mRNA from the P2 promoter.
Methylation-specific PCR
We used the bisulfite method to detect DNA methylation of Runx3. Genomic DNA (5-10 mg) was treated with bisulfite, which converts unmethylated cytosine to uracil, using the EZ DNA Methylation kit according to the manufacturer's instructions (Zymo Research, CA, USA). As a negative control for unmethylated DNA, normal lung tissue was analyzed in parallel. Amplified products were separated by 2% agarose gel electrophoresis and visualized by ethidium bromide staining. The amplified products from 27 tumor samples were purified and sequenced. The names and sequences of the primers used for methylation-specific PCR were as follows: unmethylated DNA-specific primers, UnF (5 0 -aggtttggggtattaatttt) and UnR (5 0 -caacacatccaccatcaa); methylated DNA-specific primers, MeF (5 0 -aggttcggggtattaatttc) and MeR (5 0 -caacacgtccaccatcga).
Mutational analysis of K-ras DNA was isolated from 10 spontaneous adenomas, 3 adenocarcinomas, and 10 urethane-induced adenomas found in Runx3 þ /À lungs. The samples were analyzed by PCR to detect K-ras mutations. The first exon (including codons 12 and 13) of K-ras was amplified using the forward primer 5-acatctgtagtcactgaa and the reverse primer 5 0 -tttacaagcgcacgcaga. The second exon (including codon 61) was amplified using 5 0 -actatctgacgtgctttgcc and 5 0 -tagtgcagggtaaggtaggt. The nucleotide sequences of the PCR products were analyzed by direct sequencing.
Spontaneous and urethane-induced lung tumorigenesis
Spontaneous adenoma formation was monitored in Runx3 þ /À mice and their WT littermates for a period of 18 months. To analyze urethane-induced adenoma formation, 4-week-old Runx3 þ /À and WT mice were injected intraperitoneally with urethane (ethyl carbamate; Sigma, MO, USA) (500 mg per kg body weight). Mice were monitored once per week, and then killed 12 or 16 weeks after urethane treatment, according to the guidelines of the Institutional Animal Care Committee of Chungbuk National University. Tumor type was diagnosed using standard pathological criteria by certified pathologists.
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